These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 30499710)
21. Sodium-Glucose CoTransporter-2 Inhibitor Empagliflozin Ameliorates Sunitinib-Induced Cardiac Dysfunction via Regulation of AMPK-mTOR Signaling Pathway-Mediated Autophagy. Ren C; Sun K; Zhang Y; Hu Y; Hu B; Zhao J; He Z; Ding R; Wang W; Liang C Front Pharmacol; 2021; 12():664181. PubMed ID: 33995090 [No Abstract] [Full Text] [Related]
22. The antihypertensive effectiveness and safety of dual RAAS blockade with aliskiren and valsartan. Chrysant SG Drugs Today (Barc); 2010 Mar; 46(3):151-62. PubMed ID: 20467589 [TBL] [Abstract][Full Text] [Related]
23. Azilsartan, aliskiren, and combination antihypertensives utilizing renin-angiotensin-aldosterone system antagonists. Lanier G; Sankholkar K; Aronow WS Am J Ther; 2014; 21(5):419-35. PubMed ID: 22975662 [TBL] [Abstract][Full Text] [Related]
24. Aliskiren: an oral renin inhibitor for the treatment of hypertension. Lam S; Choy M Cardiol Rev; 2007; 15(6):316-23. PubMed ID: 18090068 [TBL] [Abstract][Full Text] [Related]
25. Activation of the Renin-Angiotensin System Promotes Colitis Development. Shi Y; Liu T; He L; Dougherty U; Chen L; Adhikari S; Alpert L; Zhou G; Liu W; Wang J; Deb DK; Hart J; Liu SQ; Kwon J; Pekow J; Rubin DT; Zhao Q; Bissonnette M; Li YC Sci Rep; 2016 Jun; 6():27552. PubMed ID: 27271344 [TBL] [Abstract][Full Text] [Related]
26. Combination renin-angiotensin system blockade with the renin inhibitor aliskiren in hypertension. Doulton TW; MacGregor GA J Renin Angiotensin Aldosterone Syst; 2009 Dec; 10(4):185-9. PubMed ID: 19617273 [TBL] [Abstract][Full Text] [Related]
27. Aliskiren, an orally effective renin inhibitor, provides antihypertensive efficacy alone and in combination with valsartan. Pool JL; Schmieder RE; Azizi M; Aldigier JC; Januszewicz A; Zidek W; Chiang Y; Satlin A Am J Hypertens; 2007 Jan; 20(1):11-20. PubMed ID: 17198906 [TBL] [Abstract][Full Text] [Related]
29. Pharmacologic demonstration of the synergistic effects of a combination of the renin inhibitor aliskiren and the AT1 receptor antagonist valsartan on the angiotensin II-renin feedback interruption. Azizi M; Ménard J; Bissery A; Guyenne TT; Bura-Rivière A; Vaidyanathan S; Camisasca RP J Am Soc Nephrol; 2004 Dec; 15(12):3126-33. PubMed ID: 15579516 [TBL] [Abstract][Full Text] [Related]
30. [Renin inhibition and the kidney]. Ecder T Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():28-31. PubMed ID: 20019474 [TBL] [Abstract][Full Text] [Related]
31. The renin inhibitor aliskiren as novel treatment for cardiovascular disease. Saez AO; Philipp T; Nürnberger J Recent Pat Cardiovasc Drug Discov; 2006 Nov; 1(3):233-40. PubMed ID: 18221088 [TBL] [Abstract][Full Text] [Related]
32. The comparative efficacy of renin-angiotensin system blockers in schistosomal hepatic fibrosis. Parreira NA; Ramalho FS; Augusto MJ; Silva DM; Prado CM; Elias Júnior J; Rodrigues V; Ramalho LNZ Exp Parasitol; 2018 Aug; 191():9-18. PubMed ID: 29890165 [TBL] [Abstract][Full Text] [Related]
33. Direct renin inhibition: extricating facts from façades. Juncos L Ther Adv Cardiovasc Dis; 2013 Jun; 7(3):153-67. PubMed ID: 23487045 [TBL] [Abstract][Full Text] [Related]
35. Aliskiren prevents cardiovascular complications and pancreatic injury in a mouse model of obesity and type 2 diabetes. Dong YF; Liu L; Kataoka K; Nakamura T; Fukuda M; Tokutomi Y; Nako H; Ogawa H; Kim-Mitsuyama S Diabetologia; 2010 Jan; 53(1):180-91. PubMed ID: 19894030 [TBL] [Abstract][Full Text] [Related]
36. Aliskiren reduces blood pressure and suppresses plasma renin activity in combination with a thiazide diuretic, an angiotensin-converting enzyme inhibitor, or an angiotensin receptor blocker. O'Brien E; Barton J; Nussberger J; Mulcahy D; Jensen C; Dicker P; Stanton A Hypertension; 2007 Feb; 49(2):276-84. PubMed ID: 17159081 [TBL] [Abstract][Full Text] [Related]
37. [Direct renin inhibitor aliskiren in the treatment of cardiovascular and renal diseases]. Horký K Vnitr Lek; 2010 Feb; 56(2):120-6. PubMed ID: 20329582 [TBL] [Abstract][Full Text] [Related]
38. Renin inhibition by aliskiren prevents atherosclerosis progression: comparison with irbesartan, atenolol, and amlodipine. Nussberger J; Aubert JF; Bouzourene K; Pellegrin M; Hayoz D; Mazzolai L Hypertension; 2008 May; 51(5):1306-11. PubMed ID: 18391092 [TBL] [Abstract][Full Text] [Related]
39. Effects of the oral direct renin inhibitor aliskiren in patients with symptomatic heart failure. McMurray JJ; Pitt B; Latini R; Maggioni AP; Solomon SD; Keefe DL; Ford J; Verma A; Lewsey J; Circ Heart Fail; 2008 May; 1(1):17-24. PubMed ID: 19808266 [TBL] [Abstract][Full Text] [Related]
40. The Cardioprotective Role of Flaxseed in the Prevention of Doxorubicin- and Trastuzumab-Mediated Cardiotoxicity in C57BL/6 Mice. Asselin CY; Lam A; Cheung DYC; Eekhoudt CR; Zhu A; Mittal I; Mayba A; Solati Z; Edel A; Austria JA; Aukema HM; Ravandi A; Thliveris J; Singal PK; Pierce GN; Niraula S; Jassal DS J Nutr; 2020 Sep; 150(9):2353-2363. PubMed ID: 32510147 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]